Emergent BioSolutions Receives New Contract for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
On Sept. 9, 2025, Emergent BioSolutions announced that a contract modification has been executed in the amount of…
On Sept. 9, 2025, Emergent BioSolutions announced that a contract modification has been executed in the amount of…
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
On Jul. 19, 2024, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
On Mar. 26, 2024, the National Academies of Sciences, Engineering, and Medicine released a report that says that…
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
On Aug. 29, 2022, the U.S. Department of Health and Human Services (HHS) announced it had provided approximately…
On Aug. 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for the…
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
On Jul. 6, 2022, LabCorp announced that it had begun testing for mpox using the U.S. Centers for…
On Dec. 1, 2021, SIGA Technologies announced that Health Canada had approved oral TPOXX (tecovirimat) as an extraordinary…
Our Life-Saving Vaccines cartoon illustrates four invaluable vaccines that have affected human civilization throughout history from smallpox and…
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
On Jun. 4, 2021, The U.S. Food and Drug Administration (FDA) approved Chimerix’s Tembexa (brincidofovir) tablets and oral…
On Jan. 13, 2021, SIGA Technologies announced that the Public Health Agency of Canada had awarded a contract…
On Dec. 7, 2020, Chimerix announced the U.S. Food and Drug Administration (FDA) had accepted the filing of a…
On Oct. 8, 2020, SIGA Technologies announced that the Public Health Agency of Canada (PHAC) has issued an…
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of…
On Jun. 15, 2020, SIGA Technologies announced that it had been awarded a multi-year contract from the United…
On Apr. 28, 2020, Chimerix announced it had received clearance from the FDA for a rolling submission of…
On Feb. 26, 2020, Southern Research announced today that it has entered into a strategic collaboration with New…
On Sept. 24, 2019, Bavarian Nordic announced that the U.S. Food and Drug Administration (FDA) had approved JYNNEOS™…
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
On Jun. 8, 2015, the American Medical Association adopted a new policyᅠthat recommended that states have in place…
On Apr. 29, 2015, the Pan American Health Organization ᅠdeclared that the Americas region has become the first…
On Jun. 28, 2011, during the 37th United Nations Food and Agriculture Organization Conference, the 192 Member countries…
On Jul. 13, 2010, Bavarian Nordic announced that it had delivered 1 million doses of its smallpox vaccine…